Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Oncobiologics, Inc. (OTLK) had Free Cash Flow per Share of $-1.49 for the most recently reported fiscal year, ending 2025-09-30.
| Income Statement Financials | |
$1.41M |
|
$-62.42M |
|
$1.36M |
|
$0.06M |
|
$68.48M |
|
$-67.06M |
|
$3.08M |
|
$-63.98M |
|
$-63.98M |
|
$-62.42M |
|
$-62.42M |
|
$-62.42M |
|
$-62.42M |
|
$-67.06M |
|
$-66.94M |
|
34.80M |
|
34.80M |
|
$-1.79 |
|
$-1.79 |
|
| Balance Sheet Financials | |
$17.39M |
|
-- |
|
$1.20M |
|
$18.58M |
|
$45.81M |
|
-- |
|
$4.96M |
|
$50.77M |
|
$-32.19M |
|
$-32.19M |
|
$-32.19M |
|
53.89M |
|
| Cash Flow Statement Financials | |
$-51.83M |
|
-- |
|
$44.98M |
|
$14.93M |
|
$8.08M |
|
$-6.84M |
|
$8.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.38 |
|
-- |
|
-- |
|
-- |
|
-0.93 |
|
4.05% |
|
-4744.25% |
|
-4744.25% |
|
-4735.97% |
|
-4526.01% |
|
-4416.22% |
|
$-51.83M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.41 |
|
0.95 |
|
384.99 |
|
193.94% |
|
193.94% |
|
-335.90% |
|
193.94% |
|
$-0.60 |
|
|
Free Cash Flow per Share |
$-1.49 |
$-1.49 |
|